High GATA3 expression correlated with poor survival in PTCL patients and with tumor-associated macrophage (TAM) infiltration, as indicated by the presence of CD68-positive cells. This evidence concerns the gene GATA3 and mature T-cell and NK-cell non-Hodgkin lymphoma.